Annual Drug Patent Expirations for UTIBRON
Utibron is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.
Drug patent litigation for UTIBRON.
This drug has three hundred and forty-two patent family members in forty-four countries.
The generic ingredient in UTIBRON is glycopyrrolate; indacaterol maleate. One supplier is listed for this compound. Additional details are available on the glycopyrrolate; indacaterol maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
